Did you notice the wording with respect to the drug?
A bit different from their earlier stance with moving forward with trials.
"We remain confident that our continued prosecution of our patent related to the Company’s drug candidate CVSI-007 should result in an issued patent with proprietary technology.”
It seems the previous press release raised some eyebrows.